# BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
> **ANDA040885** · Abbreviated New Drug Application (Generic) · Sponsor: LGM PHARMA · Approved 2009-11-16
## Drug
- **FDA Application Number:** ANDA040885
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
- **Generic name:** BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE
- **Active ingredients:** ACETAMINOPHEN; BUTALBITAL; CAFFEINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LGM PHARMA
- **Manufacturer:** Actavis Pharma, Inc.
- **First approval:** 2009-11-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040885)
---
*AI Analytics · CC0 1.0*